$30.99
2.599.12%
Last update: Nov 6, 4:00 PM
Immunocore Holdings PLC (IMCR) Stock Price, Quote, News & History
IMCRNASDAQ
Morgan Stanley downgrades Amicus Therapeutics, Immunocore, and Immuneering, citing pricing challenges, pipeline updates, and cautious growth outlooks.
You can purchase shares of Immunocore Holdings (NASDAQ:IMCR) through any online brokerage.
Other companies in Immunocore Holdings’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Immunocore Holdings has a consensus price target of $62.27.
The stock price for Immunocore Holdings (NASDAQ: IMCR) is $30.99 last updated November 6, 2026 at 4:00 PM EST.
There are no upcoming dividends for Immunocore Holdings.
Immunocore Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for Immunocore Holdings.
Immunocore Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease,...
